Navigation Links
FANTOM findings boost for biologists
Date:4/20/2009

Genomic regulatory blocks have unique features that may explain their ability to respond to regulatory inputs from very long distances, according to a special thematic series of companion articles from the FANTOM4 consortium. This research, to be published across a number of BioMed Central's open access journals, including Genome Biology and BMC Bioinformatics, provide further insight into HCNE (highly conserved non-coding element) mediated long-range gene regulation at the core of animal multicellularity regulation.

Now at its fourth stage, FANTOM4, prominently led by OSC's Yoshihide Hayashizaki, has culminated after over three years of research. The center joined forces with scientists from research centers and universities in Australia, Switzerland, Norway, South Africa, Sweden, Canada, Denmark, Italy, Germany, Singapore, UK and the United States to publish three milestone papers in the journal Nature Genetics, along side the companion articles in BioMed Central, that challenge current notions of how genes are controlled in mammals.

In one Genome Biology article, researchers have created a novel database and set of interfaces to interpret biological networks and compare large high-throughput expression datasets. For more details please access the database (http://fantom.gsc.riken.jp/4/edgeexpress/)

Another study helps address major challenges in genomics including unravelling the orchestration of correct gene expression. FANTOM researchers have developed a suite of computer programs to identify chromatin conformation signatures, which could provide a completely novel class of human disease biomarkers. Further details of the software are available online at http://dostielab.biochem.mcgill.ca/

The international FANTOM4 research collaboration yielded a wide range of genome-scale data, including 24 million mRNA 5'-reads (CAGE tags) and microarray expression profiles along a differentiation time course of the human THP-1 cell line and data regarding chromatin status. These data are detailed in a new article from Genome Biology, and are also available as an integrated web resource (http://fantom.gsc.riken.jp/4/).

Further research published in BMC Bioinformatics highlights two new data-driven normalization methods for quantitative reverse transcriptase polymerase chain reaction (qPCR) experiments with larger data sets. Another study published in Genome Biology includes the first genome-wide analysis of EGR-1 binding sites implicated in cell differentiation in human monoblastoma THP-1 cells.

Dr. Harukazu Suzuki, the scientific coordinator said, "We are proud that we have created groundbreaking research in understanding more about how genes regulate cells at the molecular level and we want to acknowledge all consortium members for their great contribution to the research effort."

These are the first papers to be published from the consortium using BioMed Central's new cross-journal thematic series ability. And there are more to follow - a full list is available from the FANTOM4 series homepage (http://www.biomedcentral.com/series/FANTOM4)


'/>"/>

Contact: Charlotte Webber
charlotte.webber@biomedcentral.com
44-203-192-2216
BioMed Central
Source:Eurekalert

Related biology news :

1. Findings show insulin -- not genes -- linked to obesity
2. International climate change researchers meet, review latest findings
3. Therapeutic cloning gets a boost with new research findings
4. New research findings may enable earlier diagnosis of uterine cancer
5. Nearly a century later, new findings support Warburg theory of cancer
6. September 2007 Sumatran earthquakes research findings
7. More findings on gene involved in childhood asthma
8. Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
9. International conference to release new findings on smell and taste
10. New findings on immune system in amphibians
11. Study findings show infection control intervention helps keep kids in school
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. ... the faculty of the University of North Carolina Kenan-Flagler Business School ... entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading ...
Breaking Biology Technology: